Health Care Company Pays $7.75M To Resolve DEA Drug Diversion Probe
Health care company McLaren Health Care Corp. will pay $7.75 million to resolve a federal investigation that two of its former retail pharmacies violated the Controlled Substances Act by failing to...To view the full article, register now.
Already a subscriber? Click here to view full article